NCT00185861View on ClinicalTrials.gov

Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

April 30, 2009

Conditions
Brain Cancer
Interventions
DRUG

Arsenic Trioxide

PROCEDURE

Stereotactic radiosurgery

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (2)

Cephalon
CTI BioPharma
All Listed Sponsors
collaborator

Cephalon

INDUSTRY

collaborator

CTI BioPharma

INDUSTRY

lead

Stanford University

OTHER

NCT00185861 - Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma | Biotech Hunter | Biotech Hunter